| FIDELITY FUNDS 2 - TRANSITION MATERIALS I-ACC-USD | RVI MATERIAS PRIMAS | 73,90% | · | · | · |
| GOLDMAN SACHS EMERGING MARKETS EX-CHINA CORE EQUITY PORTFOLIO I (CLOSE) GBP CAP | RVI EMERGENTES | 73,85% | · | · | · |
| GOLDMAN SACHS EMERGING MARKETS EX-CHINA CORE EQUITY PORTFOLIO R (CLOSE) GBP CAP | RVI EMERGENTES | 73,75% | · | · | · |
| SCHRODER ISF EMERGING MARKETS A ACC AUD (HEDGED) | RVI EMERGENTES | 73,74% | 89,22% | 26,36% | 129,21% |
| GOLDMAN SACHS EMERGING MARKETS EX-CHINA CORE EQUITY PORTFOLIO R (CLOSE) USD CAP | RVI EMERGENTES | 73,68% | · | · | · |
| FIDELITY FUNDS 2 - TRANSITION MATERIALS Y-ACC USD | RVI MATERIAS PRIMAS | 73,61% | · | · | · |
| GOLDMAN SACHS EMERGING MARKETS EX-CHINA CORE EQUITY PORTFOLIO P (CLOSE) GBP CAP | RVI EMERGENTES | 73,53% | · | · | · |
| GOLDMAN SACHS EMERGING MARKETS EX-CHINA CORE EQUITY PORTFOLIO P (CLOSE) USD CAP | RVI EMERGENTES | 73,48% | · | · | · |
| NEUBERGER BERMAN NEXT GENERATION CONNECTIVITY USD A ACC | RVI TECNOLOGÍA | 73,46% | 207,54% | 129,64% | · |
| WELLINGTON ASIA TECHNOLOGY FUND S USD ACC | RVI TECNOLOGÍA | 73,45% | 145,99% | 121,63% | · |
| FRANKLIN BIOTECHNOLOGY DISCOVERY N (ACC) USD | RVI BIOTECNOLOGÍA | 73,39% | 68,73% | 61,05% | 139,10% |
| AMUNDI MSCI NEW ENERGY UCITS ETF DIST | RVI ENERGÍA | 73,36% | 24,67% | 21,71% | 170,44% |
| FIDELITY FUNDS 2 - TRANSITION MATERIALS A-ACC-EUR | RVI MATERIAS PRIMAS | 73,22% | · | · | · |
| JANUS HENDERSON HF - BIOTECHNOLOGY H2 EUR HEDGED | RVI BIOTECNOLOGÍA | 73,14% | 72,63% | · | · |
| WELLINGTON ASIA TECHNOLOGY FUND N USD ACC | RVI TECNOLOGÍA | 73,12% | 144,60% | 119,54% | · |
| NEUBERGER BERMAN NEXT GENERATION CONNECTIVITY EUR M ACC | RVI TECNOLOGÍA | 72,94% | 198,31% | 120,58% | · |
| PICTET - BIOTECH HR EUR | RVI BIOTECNOLOGÍA | 72,84% | 55,48% | 29,02% | 82,22% |
| NEUBERGER BERMAN NEXT GENERATION CONNECTIVITY SGD A ACC (HEDGED) | RVI TECNOLOGÍA | 72,83% | 199,80% | 120,46% | · |
| GOLDMAN SACHS EMERGING MARKETS EX-CHINA CORE EQUITY PORTFOLIO BASE (CLOSE) USD CAP | RVI EMERGENTES | 72,58% | · | · | · |
| JANUS HENDERSON HF - BIOTECHNOLOGY A2 EUR HEDGED | RVI BIOTECNOLOGÍA | 72,58% | 69,20% | · | · |
